Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective, Volume 22 (Methods and Principles in Medicinal Chemistry) - Hardcover
Chemogenomics brings together the most powerful concepts in modern chemistry and biology, linking combinatorial chemistry with genomics and proteomics.
This first reference devoted to the topic covers all stages of the early drug discovery process, from target selection to compound library and lead design.
With the combined expertise of 20 research groups from academia and leading pharmaceutical companies, this is a must-have for every drug developer and medicinal chemist applying the powerful methods of chemogenomics to speed up the drug discovery process.
This first reference devoted to the topic covers all stages of the early drug discovery process, from target selection to compound library and lead design.
With the combined expertise of 20 research groups from academia and leading pharmaceutical companies, this is a must-have for every drug developer and medicinal chemist applying the powerful methods of chemogenomics to speed up the drug discovery process.
"synopsis" may belong to another edition of this title.
From the Back Cover:
Chemogenomics brings together the most powerful concepts in modern chemistry and biology, linking combinatorial chemistry with genomics and proteomics.
This first reference devoted to the topic covers all stages of the early drug discovery process, from target selection to compound library and lead design.
From the Contents:
* Masterkeys and Privileged Structures
* Drug Discovery from Side Effects
* Chemical Genetics in Drug Discovery
* Knowledge-based Discovery of Biological Targets
* Chemical Kinomics
* Compound Library and Template Design
* Computational Filters in Lead Generation
* Ligand-based Design of Focused Libraries
* Natural Product-derived Combinatorial Libraries
With the combined expertise of 15 research groups from academia and leading pharmaceutical companies, this reference is indispensable reading for every drug developer and medicinal chemist who wants to stay ahead in the search for new and improved drugs.
About the Author:
This first reference devoted to the topic covers all stages of the early drug discovery process, from target selection to compound library and lead design.
From the Contents:
* Masterkeys and Privileged Structures
* Drug Discovery from Side Effects
* Chemical Genetics in Drug Discovery
* Knowledge-based Discovery of Biological Targets
* Chemical Kinomics
* Compound Library and Template Design
* Computational Filters in Lead Generation
* Ligand-based Design of Focused Libraries
* Natural Product-derived Combinatorial Libraries
With the combined expertise of 15 research groups from academia and leading pharmaceutical companies, this reference is indispensable reading for every drug developer and medicinal chemist who wants to stay ahead in the search for new and improved drugs.
Hugo Kubinyi studied chemistry in Vienna, Austria. After his Ph.D. thesis at the Max Planck Institute of Biochemistry in Munich he continued as a PostDoc at the German Cancer Research Centre in Heidelberg. In 1966 he joined Knoll AG, later a subsidiary of BASF AG, and in 1985 he moved to BASF AG. Since 1987, until his retirement in summer 2001, he was responsible for the Molecular Modelling, Protein Crystallography and Drug Design group of BASF, since early 1998 also for Combinatorial Chemistry in the Life Sciences.
He is Professor of Pharmaceutical Chemistry at the University of Heidelberg, former Chair of The QSAR and Modelling Society, and IUPAC Fellow. From his scientific work resulted five books on QSAR, 3D QSAR, and Drug
Design (the German book "Wirkstoffdesign" received the 1999 Book Award of the FCI, Association of Chemical Industry) and about 90 publications.
He is a member of several Scientific Advisory Boards, coeditor of the Wiley-VCH book series "Methods and Principles in Medicinal Chemistry", and member of the Editorial Boards of several scientific journals.
Gerhard Müller graduated in Organic Chemistry from the University of Frankfurt/Main (Germany) and received his PhD in 1992 at the Technical University of Munich. After two years in the Medicinal Chemistry department of Glaxo Verona (Italy), he joined the central research facility of the Bayer AG, Leverkusen. From 1998 onwards he was project manager of a target family approach in medicinal chemistry. From 2001 to 2003 he headed the chemistry section of Organon's Lead Discovery Unit in Oss (The Netherlands). Since summer 2003, Gerhard Müller is the chief scientific officer of the Munich-based biotech company Axxima Pharmaceuticals AG.
He is Professor of Pharmaceutical Chemistry at the University of Heidelberg, former Chair of The QSAR and Modelling Society, and IUPAC Fellow. From his scientific work resulted five books on QSAR, 3D QSAR, and Drug
Design (the German book "Wirkstoffdesign" received the 1999 Book Award of the FCI, Association of Chemical Industry) and about 90 publications.
He is a member of several Scientific Advisory Boards, coeditor of the Wiley-VCH book series "Methods and Principles in Medicinal Chemistry", and member of the Editorial Boards of several scientific journals.
Gerhard Müller graduated in Organic Chemistry from the University of Frankfurt/Main (Germany) and received his PhD in 1992 at the Technical University of Munich. After two years in the Medicinal Chemistry department of Glaxo Verona (Italy), he joined the central research facility of the Bayer AG, Leverkusen. From 1998 onwards he was project manager of a target family approach in medicinal chemistry. From 2001 to 2003 he headed the chemistry section of Organon's Lead Discovery Unit in Oss (The Netherlands). Since summer 2003, Gerhard Müller is the chief scientific officer of the Munich-based biotech company Axxima Pharmaceuticals AG.
"About this title" may belong to another edition of this title.
- PublisherWiley-VCH
- Publication date2004
- ISBN 10 352730987X
- ISBN 13 9783527309870
- BindingHardcover
- Edition number1
- Number of pages487
- EditorKubinyi Hugo, Müller Gerhard
Buy New
Learn more about this copy
US$ 202.82
Shipping:
FREE
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
CHEMOGENO MICS IN DRUG DISCOVERY: A MEDICINAL CHEMISTRY PERSPECTIVE (METHODS AND PRINCIPLES IN MEDICINAL CHEMISTRY)
Seller:
Rating
Book Description Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT23-256099
Buy New
US$ 202.82
Convert currency
Stock Image
CHEMOGENOMICS IN DRUG DISCOVERY:
Seller:
Rating
Book Description Condition: New. New. In shrink wrap. Looks like an interesting title! 2.29. Seller Inventory # Q-352730987X
Buy New
US$ 232.92
Convert currency